Published in Am J Respir Crit Care Med on August 29, 2007
Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation. Thorax (2008) 2.10
CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol (2008) 1.51
Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J Immunol (2012) 1.48
Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells (2011) 1.33
Treatment of allergic asthma: modulation of Th2 cells and their responses. Respir Res (2011) 1.31
Primary murine airway smooth muscle cells exposed to poly(I,C) or tunicamycin synthesize a leukocyte-adhesive hyaluronan matrix. J Biol Chem (2008) 1.26
c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis. Am J Respir Cell Mol Biol (2008) 1.26
Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13. Respir Res (2010) 1.24
A protective role for periostin and TGF-β in IgE-mediated allergy and airway hyperresponsiveness. Clin Exp Allergy (2011) 1.14
PI3K gamma-deficient mice have reduced levels of allergen-induced eosinophilic inflammation and airway remodeling. Am J Physiol Lung Cell Mol Physiol (2008) 1.12
Inhaled salmeterol and/or fluticasone alters structure/function in a murine model of allergic airways disease. Respir Res (2010) 1.08
Tgf-Beta isoform specific regulation of airway inflammation and remodelling in a murine model of asthma. PLoS One (2010) 1.07
Pathophysiological features of asthma develop in parallel in house dust mite-exposed neonatal mice. Am J Respir Cell Mol Biol (2009) 1.06
Acute exercise decreases airway inflammation, but not responsiveness, in an allergic asthma model. Am J Respir Cell Mol Biol (2008) 1.04
The presence of CD14 overcomes evasion of innate immune responses by virulent Francisella tularensis in human dendritic cells in vitro and pulmonary cells in vivo. Infect Immun (2009) 1.03
Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF). Respir Res (2010) 1.01
Deficiency of endothelial heparan sulfates attenuates allergic airway inflammation. J Immunol (2009) 1.00
Systems biology approaches to understanding Epithelial Mesenchymal Transition (EMT) in mucosal remodeling and signaling in asthma. World Allergy Organ J (2014) 0.97
Variants in TGFB1, dust mite exposure, and disease severity in children with asthma. Am J Respir Crit Care Med (2008) 0.96
The complex relationship between inflammation and lung function in severe asthma. Mucosal Immunol (2014) 0.93
The receptor for advanced glycation end products is a central mediator of asthma pathogenesis. Am J Pathol (2012) 0.92
Strain-dependent activation of NF-kappaB in the airway epithelium and its role in allergic airway inflammation. Am J Physiol Lung Cell Mol Physiol (2009) 0.92
Preservation of micro-architecture and angiogenic potential in a pulmonary acellular matrix obtained using intermittent intra-tracheal flow of detergent enzymatic treatment. Biomaterials (2013) 0.90
Aldose reductase inhibition prevents allergic airway remodeling through PI3K/AKT/GSK3β pathway in mice. PLoS One (2013) 0.87
Lyn mitigates mouse airway remodeling by downregulating the TGF-β3 isoform in house dust mite models. J Immunol (2013) 0.86
Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells. J Allergy Clin Immunol (2015) 0.85
TGF-beta can leave you breathless. Curr Opin Pharmacol (2009) 0.85
Molecular Mechanisms of Airway Hyperresponsiveness in a Murine Model of Steroid-Resistant Airway Inflammation. J Immunol (2016) 0.85
Epistatic interactions between Tgfb1 and genetic loci, Tgfbm2 and Tgfbm3, determine susceptibility to an asthmatic stimulus. Proc Natl Acad Sci U S A (2012) 0.84
Functional effects of TGF-β1 on mesenchymal stem cell mobilization in cockroach allergen-induced asthma. J Immunol (2014) 0.83
Allergen-induced coexpression of bFGF and TGF-β1 by macrophages in a mouse model of airway remodeling: bFGF induces macrophage TGF-β1 expression in vitro. Int Arch Allergy Immunol (2010) 0.83
Bronchial epithelial cells produce IL-5: implications for local immune responses in the airways. Cell Immunol (2010) 0.82
Absence of c-Jun NH2-terminal kinase 1 protects against house dust mite-induced pulmonary remodeling but not airway hyperresponsiveness and inflammation. Am J Physiol Lung Cell Mol Physiol (2014) 0.82
Environmental tobacco smoke exposure does not prevent corticosteroids reducing inflammation, remodeling, and airway hyperreactivity in mice exposed to allergen. Am J Physiol Lung Cell Mol Physiol (2009) 0.81
Chronic alcohol induces M2 polarization enhancing pulmonary disease caused by exposure to particulate air pollution. Alcohol Clin Exp Res (2013) 0.81
Airway Hyperresponsiveness and Inflammation: Causation, Correlation, or No Relation? J Allergy Ther (2012) 0.80
Toll-like receptor-9 agonist inhibits airway inflammation, remodeling and hyperreactivity in mice exposed to chronic environmental tobacco smoke and allergen. Int Arch Allergy Immunol (2009) 0.80
The immunoregulatory and fibrotic roles of activin A in allergic asthma. Clin Exp Allergy (2015) 0.80
Bystander immunotherapy as a strategy to control allergen-driven airway inflammation. Mucosal Immunol (2014) 0.79
A Novel CD4(+) T Cell-Dependent Murine Model of Pneumocystis-driven Asthma-like Pathology. Am J Respir Crit Care Med (2016) 0.79
Surfactant protein D attenuates sub-epithelial fibrosis in allergic airways disease through TGF-β. Respir Res (2014) 0.78
ADAM metallopeptidase domain 33 (ADAM33): a promising target for asthma. Mediators Inflamm (2014) 0.78
Airway hyperresponsiveness is associated with airway remodeling but not inflammation in aging Cav1-/- mice. Respir Res (2013) 0.78
Role of thrombin-activatable fibrinolysis inhibitor in allergic bronchial asthma. Lung (2011) 0.78
CTGF upregulation correlates with MMP-9 level in airway remodeling in a murine model of asthma. Arch Med Sci (2016) 0.77
Pharyngeal microflora disruption by antibiotics promotes airway hyperresponsiveness after respiratory syncytial virus infection. PLoS One (2012) 0.77
Genetic variants in TNFα, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthma. J Immunotoxicol (2015) 0.76
Aryl hydrocarbon receptor (AhR) modulates cockroach allergen-induced immune responses through active TGFβ1 release. Mediators Inflamm (2014) 0.76
Immunization against TGF-β1 reduces collagen deposition but increases sustained inflammation in a murine asthma model. Hum Vaccin Immunother (2016) 0.75
Effect of tumor necrosis factor family member LIGHT (TNFSF14) on the activation of basophils and eosinophils interacting with bronchial epithelial cells. Mediators Inflamm (2014) 0.75
Bromodomain and Extra-Terminal Protein Inhibition Attenuates Neutrophil-dominant Allergic Airway Disease. Sci Rep (2017) 0.75
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med (2003) 26.05
Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature (2003) 20.48
Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature (1992) 16.46
TGF-beta signaling and the fibrotic response. FASEB J (2004) 9.81
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet (2005) 9.62
Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J (1979) 8.95
Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol (1999) 5.51
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 4.71
Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol (1985) (1992) 3.79
Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol (2005) 3.48
Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol (1991) 3.38
Airway remodeling in asthma. J Clin Invest (1999) 3.19
Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest (2004) 3.06
Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med (2004) 2.84
Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1997) 2.84
The role of transforming growth factor beta in lung development and disease. Chest (2004) 2.83
A reevaluation of the validity of unrestrained plethysmography in mice. J Appl Physiol (1985) (2002) 2.63
Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47
The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis (1993) 2.23
Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol (2005) 2.22
Mechanics of airway narrowing. Am Rev Respir Dis (1986) 2.18
Release of biologically active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2003) 2.14
Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med (2003) 1.98
Measuring lung function in mice: the phenotyping uncertainty principle. J Appl Physiol (1985) (2003) 1.93
Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. Am J Respir Crit Care Med (2000) 1.88
Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest (1997) 1.71
Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J Clin Invest (2004) 1.70
Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Respir Crit Care Med (2004) 1.66
Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation. Am J Pathol (2002) 1.66
Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. J Immunol (2007) 1.63
Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood (1996) 1.51
Reversal of airway hyperresponsiveness by induction of airway mucosal CD4+CD25+ regulatory T cells. J Exp Med (2006) 1.50
TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice. Thorax (2003) 1.45
Clinical relevance of airway remodelling in airway diseases. Eur Respir J (2007) 1.44
CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest (2000) 1.43
Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am J Physiol Lung Cell Mol Physiol (2001) 1.43
Intrinsic and antigen-induced airway hyperresponsiveness are the result of diverse physiological mechanisms. J Appl Physiol (1985) (2006) 1.39
Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction. Am J Respir Crit Care Med (1995) 1.37
Airway wall remodeling: friend or foe? J Appl Physiol (1985) (2003) 1.33
Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice. Am J Respir Cell Mol Biol (2004) 1.27
Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation. Am J Respir Cell Mol Biol (2001) 1.24
Acute allergen-induced airway remodeling in atopic asthma. Am J Respir Cell Mol Biol (2004) 1.21
Activation of TGF-beta/Smad2 signaling is associated with airway remodeling in asthma. J Allergy Clin Immunol (2002) 1.15
Epithelial expression of profibrotic mediators in a model of allergen-induced airway remodeling. Am J Respir Cell Mol Biol (2004) 1.14
IL-5-induced airway eosinophilia--the key to asthma? Immunol Rev (2001) 1.12
Reduced expression of transforming growth factor beta 1 exacerbates pathology in an experimental asthma model. Eur J Immunol (2005) 1.11
Minimal effects on immune parameters following chronic anti-TGF-beta monoclonal antibody administration to normal mice. Immunopharmacol Immunotoxicol (2003) 1.05
Expression of growth factors by airway epithelial cells in a model of chronic asthma: regulation and relationship to subepithelial fibrosis. Clin Exp Allergy (2004) 1.04
Recombinant basic fibroblast growth factor inhibits the airway hyperresponsiveness, mucus production, and lung inflammation induced by an allergen challenge. J Allergy Clin Immunol (2007) 1.03
Nonlinearity of respiratory mechanics during bronchoconstriction in mice with airway inflammation. J Appl Physiol (1985) (2002) 1.02
Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells. Int Immunol (2007) 0.96
Gastric lesions in transforming growth factor beta-1 heterozygous mice. Lab Invest (1996) 0.95
Role of bronchial basement membrane in airway collapse. J Appl Physiol (1985) (1991) 0.89
Effects of overexpression of IL-10, IL-12, TGF-beta and IL-4 on allergen induced change in bronchial responsiveness. Respir Res (2006) 0.86
Fluticasone inhibits the progression of allergen-induced structural airway changes. Clin Exp Allergy (2002) 0.84
An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med (2011) 5.53
Defining a link with asthma in mice congenitally deficient in eosinophils. Science (2004) 5.20
Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med (2007) 4.40
TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol (2008) 3.42
Exercise for fun and profit: joint statement on exercise by the American Thoracic Society and the American College of Chest Physicians. Chest (2004) 2.76
Knowledge and use of office spirometry for the detection of chronic obstructive pulmonary disease by primary care physicians. Respir Care (2005) 2.72
A reevaluation of the validity of unrestrained plethysmography in mice. J Appl Physiol (1985) (2002) 2.63
Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med (2005) 2.56
Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol (2011) 2.53
Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci U S A (2006) 2.51
The allergic mouse model of asthma: normal smooth muscle in an abnormal lung? J Appl Physiol (1985) (2003) 2.44
Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. J Appl Physiol (1985) (2004) 2.43
Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci U S A (2004) 2.19
Airway hyperresponsiveness in allergically inflamed mice: the role of airway closure. Am J Respir Crit Care Med (2007) 2.16
Measuring the lung function in the mouse: the challenge of size. Respir Res (2003) 2.14
Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet (2011) 2.10
Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways. Am J Respir Cell Mol Biol (2010) 2.04
Peak pressures during manual ventilation. Respir Care (2005) 2.03
A prominent role for airway epithelial NF-kappa B activation in lipopolysaccharide-induced airway inflammation. J Immunol (2003) 1.99
Measuring lung function in mice: the phenotyping uncertainty principle. J Appl Physiol (1985) (2003) 1.93
Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations. J Appl Physiol (1985) (2002) 1.92
The role of time and pressure on alveolar recruitment. J Appl Physiol (1985) (2008) 1.92
Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenet Genomics (2009) 1.90
Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol (2009) 1.81
Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci (2012) 1.79
NF-kappa B activation in airways modulates allergic inflammation but not hyperresponsiveness. J Immunol (2004) 1.73
Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J Clin Invest (2004) 1.70
Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol (2011) 1.69
Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid Redox Signal (2006) 1.67
Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation. Am J Pathol (2002) 1.66
Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injury. Am J Physiol Lung Cell Mol Physiol (2008) 1.62
Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1. J Cell Sci (2008) 1.60
The nonallergic asthma of obesity. A matter of distal lung compliance. Am J Respir Crit Care Med (2014) 1.57
Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications. J Allergy Clin Immunol (2012) 1.57
Variation in the rapid shallow breathing index associated with common measurement techniques and conditions. Respir Care (2009) 1.55
Airway smooth muscle as a target for asthma therapy. N Engl J Med (2007) 1.54
Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J (2004) 1.53
Ablation of multiwavelet re-entry guided by circuit-density and distribution: maximizing the probability of circuit annihilation. Circ Arrhythm Electrophysiol (2013) 1.53
Redox amplification of apoptosis by caspase-dependent cleavage of glutaredoxin 1 and S-glutathionylation of Fas. J Cell Biol (2009) 1.42
Glutaredoxin-1 attenuates S-glutathionylation of the death receptor fas and decreases resolution of Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med (2014) 1.40
Nuclear factor-kappaB activation in airway epithelium induces inflammation and hyperresponsiveness. Am J Respir Crit Care Med (2008) 1.40
Intrinsic and antigen-induced airway hyperresponsiveness are the result of diverse physiological mechanisms. J Appl Physiol (1985) (2006) 1.39
ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. Am J Respir Crit Care Med (2008) 1.34
Nuclear factor kappaB, airway epithelium, and asthma: avenues for redox control. Proc Am Thorac Soc (2009) 1.31
Animal models of asthma. Am J Physiol Lung Cell Mol Physiol (2009) 1.31
Time dependence of recruitment and derecruitment in the lung: a theoretical model. J Appl Physiol (1985) (2002) 1.31
Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function. Respir Res (2010) 1.29
Extracellular matrix mechanics in lung parenchymal diseases. Respir Physiol Neurobiol (2008) 1.28
Obesity and asthma: an inflammatory disease of adipose tissue not the airway. Am J Respir Crit Care Med (2012) 1.28
In situ detection of S-glutathionylated proteins following glutaredoxin-1 catalyzed cysteine derivatization. Biochim Biophys Acta (2006) 1.27
c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis. Am J Respir Cell Mol Biol (2008) 1.26
Effect of obesity on clinical presentation and response to treatment in asthma. J Asthma (2006) 1.26
Modulation of glutaredoxin-1 expression in a mouse model of allergic airway disease. Am J Respir Cell Mol Biol (2006) 1.25
Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation. Proc Natl Acad Sci U S A (2008) 1.22
Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways. Am J Physiol Cell Physiol (2002) 1.19
Pulmonary impedance and alveolar instability during injurious ventilation in rats. J Appl Physiol (1985) (2005) 1.18
A multiscale, spatially distributed model of asthmatic airway hyper-responsiveness. J Theor Biol (2010) 1.18
Allergic rhinitis and sinusitis in asthma: differential effects on symptoms and pulmonary function. Chest (2006) 1.17
Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation. Am J Physiol Cell Physiol (2005) 1.17
Influence of airway wall stiffness and parenchymal tethering on the dynamics of bronchoconstriction. Am J Physiol Lung Cell Mol Physiol (2010) 1.16
Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol (2006) 1.16
Lung tissue mechanics as an emergent phenomenon. J Appl Physiol (1985) (2011) 1.15
Choosing the frequency of deep inflation in mice: balancing recruitment against ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol (2006) 1.14
Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration. J Immunol (2008) 1.13
The "Goldilocks effect" in cystic fibrosis: identification of a lung phenotype in the cftr knockout and heterozygous mouse. BMC Genet (2004) 1.13
On the terminology for describing the length-force relationship and its changes in airway smooth muscle. J Appl Physiol (1985) (2004) 1.12
Computational assessment of airway wall stiffness in vivo in allergically inflamed mouse models of asthma. J Appl Physiol (1985) (2008) 1.11
c-Jun N-terminal kinase 1 promotes transforming growth factor-β1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3. Am J Respir Cell Mol Biol (2010) 1.11
Influenza induces endoplasmic reticulum stress, caspase-12-dependent apoptosis, and c-Jun N-terminal kinase-mediated transforming growth factor-β release in lung epithelial cells. Am J Respir Cell Mol Biol (2011) 1.11
The synergistic interactions of allergic lung inflammation and intratracheal cationic protein. Am J Respir Crit Care Med (2007) 1.10
Alpha1-antitrypsin determines the pattern of emphysema and function in tobacco smoke-exposed mice: parallels with human disease. Am J Respir Crit Care Med (2002) 1.10
Ablation of glutaredoxin-1 attenuates lipopolysaccharide-induced lung inflammation and alveolar macrophage activation. Am J Respir Cell Mol Biol (2010) 1.10
Genome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response gene. PLoS Genet (2012) 1.09
Commentaries on Viewpoint: Airway smooth muscle and airway hyperresponsiveness in human asthma: have we chased the wrong horse? J Appl Physiol (1985) (2014) 1.08
Airway epithelial NF-κB activation promotes allergic sensitization to an innocuous inhaled antigen. Am J Respir Cell Mol Biol (2010) 1.08
Inhaled salmeterol and/or fluticasone alters structure/function in a murine model of allergic airways disease. Respir Res (2010) 1.08
Transient mechanical benefits of a deep inflation in the injured mouse lung. J Appl Physiol (1985) (2002) 1.07
Quantifying the roles of tidal volume and PEEP in the pathogenesis of ventilator-induced lung injury. Ann Biomed Eng (2011) 1.07
Exaggerated airway narrowing in mice treated with intratracheal cationic protein. J Appl Physiol (1985) (2005) 1.07
A role for sensory nerves in the late asthmatic response. Thorax (2011) 1.06